Clinical Trial

Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease

Study acronym: FABRyCar
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2026 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this work, we address the understanding of the signaling pathways involved in cardiac remodeling in human SCD through molecular imaging analysis with a fibrosis marker. Furthermore, we emphasize characterizing the cardiac remodeling process by analyzing proteomic data from SCD myocardial biopsies and by analyzing the profile of microRNAs associated with hypertrophic cardiomyopathy and their diagnostic and prognostic value.
Trial Details
NCT Number NCT07351136
Lead Sponsor Núcleo de Apoio à Investigação Clínica - FMUP
Collaborators: Universidade do Porto, SOFIE, GE Healthcare
Conditions Fabry Disease
Enrollment 20 participants
Start Date 2026-01-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-20